Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

(S)he said what!?
On October 23, the ADA announced the creation of its “ Make the Link” Diabetes and Coronary Artery Disease Resource Toolkit . Although the toolkit is originally intended...
You call that an artificial pancreas? The pathway to closed loop system.
On April 3, an FDA Advisory Committee voted an overwhelming 13-1 in favor of approving MannKind’s ultra-rapid-acting inhaled insulin Afrezza for type 1 diabetes. The...
On August 14, MannKind reported phase 3 results for the ultra-rapid-acting inhaled insulin, Afrezza. Afrezza was tested in two large 24-week trials in both type 1 and...
The evolving field of type 1 diabetes and how research should improve to get closer to finding a cure.
Struggling to find the perfect Valentine’s Day gift this year? For February 14, we ask you to extend your love to children who have diabetes but don’t have access to...
MannKind’s inhalable ultra-rapid-acting insulin Afrezza has its day at the FDA – find out what it can do for patients and how to speak up!
From August 19 to 25, the cyclists for Team Novo Nordisk headed to Colorado to race from Aspen to Denver in the third annual USA Pro Cycling Challenge . All members of...
We ask ACA expert Dr. Jack Lord all the hard questions on healthcare coverage and reimbursement.
This April 25-27, DiabetesSisters will be hosting a three-day Weekend for Women Conference for the first time in the Washington, DC area. The conference will provide...
Part 1 of our interview with the Helmsley Charitable Trust’s David Panzirer and T1D Exchange's Dana Ball.
On May 29, the American Diabetes Association (ADA) and the American Nurses Association (ANA) appeared before the California Supreme Court to argue whether designated...
On Tuesday October 15, JDRF and PureTech announced the launch of T1D Innovations, an exciting new fund that aims to supply crucial funding for the development of type 1...
The FDA released its final guidance earlier this fall on the types of mobile medical apps it will regulate. As expected, the FDA will have oversight on mobile medical...
We travel to Oregon to support test strip access for people with diabetes. Find out what transpired!
On April 9, Lilly and T1D Exchange announced a five-year research collaboration on projects designed to improve the health and wellbeing of people with type 1 diabetes...
Earlier this month, the California Supreme Court unanimously decided that public school employees can administer insulin to children as long as they have parental...
Kerri reflects on what a cure means to her.
On February 4, Dexcom announced FDA approval of the G4 Platinum CGM for children 2-17 years old in the United States. Dexcom’s G4 Platinum was previously approved in...

Pages